Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVV858 in Advanced Breast Cancer and Other Solid Tumors
NCT07288359Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Dec 2025
- Primary completion
- May 2031
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of GVV858 in breast cancer, solid tumor, prostate cancer (PCa), sponsored by Novartis. Started Dec 2025; status: recruiting.
02
Drugs
GVV858
03
Conditions
breast cancersolid tumorprostate cancer (PCa)
Beyond the preview
Go deeper on NCT07288359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288359.